Bicara Therapeutics Inc. Earnings Per Share, Basic in USD/shares from Q3 2023 to Q3 2025

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Bicara Therapeutics Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from Q3 2023 to Q3 2025.
  • Bicara Therapeutics Inc. Earnings Per Share, Basic for the quarter ending September 30, 2025 was -0.67 USD/shares, a 58.1% increase year-over-year.
  • Bicara Therapeutics Inc. Earnings Per Share, Basic for the twelve months ending September 30, 2025 was 33 USD/shares.
  • Bicara Therapeutics Inc. annual Earnings Per Share, Basic for 2024 was -4.05 USD/shares, a 95.5% increase from 2023.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)

Bicara Therapeutics Inc. Quarterly Earnings Per Share, Basic (USD/shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $33.00 -$1 +$0.93 +58.1% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-10
Q2 2025 $32.00 -$1 +$18.50 +97.4% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-12
Q1 2025 $14.00 -$1 +$18.30 +96.4% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-13
Q4 2024 -$4 $35.50 Oct 1, 2024 Dec 31, 2024 10-K 2025-03-27
Q3 2024 -$2 +$36.60 +95.8% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-10
Q2 2024 -$19 Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-12
Q1 2024 -$19 Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-13
Q3 2023 -$38 Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12

Bicara Therapeutics Inc. Annual Earnings Per Share, Basic (USD/shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$4 +$85.60 +95.5% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-27
2023 -$90 Jan 1, 2023 Dec 31, 2023 10-K 2025-03-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.